Suchergebnisse - "García Layana, Alfredo"

PubPharm (11)

1

Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study

enthalten in: Acta ophthalmologica | 2021

von Saenz-de-Viteri, M. | Recalde, S. | Fernandez-Robredo, P. | +44

2

Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients : 12-month outcomes of a randomized study

enthalten in: Acta ophthalmologica | 2020

von López Gálvez, M. | Arias Barquet, L. | S Figueroa, M. | +31

3

Evaluation of ranibizumab and aflibercept for the treatment of diabetic macular edema in daily clinical practice

enthalten in: PloS one | 2019

von Plaza-Ramos, P. | Borque, E. | García-Layana, A.

4

Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration

enthalten in: Acta ophthalmologica | 2018

von Cobos, E. | Recalde, S. | Anter, J. | +11

5

Single- and repeated-dose toxicity study of bevacizumab, ranibizumab, and aflibercept in ARPE-19 cells under normal and oxidative stress conditions

enthalten in: Biochemical pharmacology | 2016

von Saenz-de-Viteri, M. | Fernández-Robredo, P. | Hernández, M. | +4

6

INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA : SIX YEARS OUTCOME

enthalten in: Retina (Philadelphia, Pa.) | 2015

von Ruiz-Moreno, J. | Montero, J. | Araiz, J. | +5

CommentIn: Retina. 2016 Jun;36(6):e50-1. - PMID 27145253

7

Treatment of Exudative Age-related Macular Degeneration : Focus on Aflibercept

enthalten in: Drugs & aging | 2015

von García-Layana, A. | Figueroa, M. | Araiz, J. | +4

8

Current state of therapeutic strategies with ranibizumab in neovascular age-related macular degeneration

enthalten in: Current opinion in ophthalmology | 2015

von Gallego-Pinazo, R. | Figueroa, M. | García-Layana, A.

9

Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration

enthalten in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2010

von Hernández-Pastor, L. | Ortega, A. | García-Layana, A. | +1

CommentIn: Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1675; author reply 1677. - PMID 20424851

10

Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration

enthalten in: Clinical therapeutics | 2008

von Hernandez-Pastor, L. | Ortega, A. | Garcia-Layana, A. | +1